Biblio Discovery — Demo Discovery Service

8 hasil untuk "Mariana Haeberer"

Menampilkan 1–8 · 0,37 detik · RSS

  1. Artikel Jurnal

    Health inequalities by gradients of access to water and sanitation between countries in the Americas, 1990 and 2010

    Oscar J. Mújica; Mariana Haeberer; Jordan Teague dkk.

    Revista Panamericana de Salud Pública, Vol. 38 No. 5 · Portugis · DOAJ Scopus

    OBJECTIVE: To explore distributional inequality of key health outcomes as determined by access coverage to water and sanitation (WS) between countries in the Region of the Americas. METHODS: An ecological study was designed to explore the magnitude and change-over-time of standard gap and gradient…

  2. Artikel Jurnal Teks lengkap

    Social inequalities in tobacco-attributable mortality in Spain. The intersection between age, sex and educational level

    Mariana Haeberer; Inmaculada León-Gómez; Beatriz Pérez-Gómez dkk.

    PLOS ONE, Vol. 15 No. 9 · 2020 · Inggris · PLOS Scopus

    Introduction: First study of social inequalities in tobacco-attributable mortality (TAM) in Spain considering the joint influence of sex, age, and education (intersectional perspective). Methods: Data on all deaths due to cancer, cardiometabolic and respiratory diseases among people aged ≥35 years…

    Juga tersedia di: DOAJ

  3. Artikel Jurnal

    Respiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the Global Burden of Disease frameworkResearch in context

    Katrin Burkart; Caihua Liang; Quinn Rafferty dkk.

    EClinicalMedicine, Vol. 85 · 2025 · Inggris · DOAJ Scopus

    Summary: Background: Respiratory syncytial virus (RSV) in adults is typically underdiagnosed due to non-specific symptoms, infrequent routine testing, and low-test sensitivity; consequently, its impact is not well understood. To address this gap, we developed a novel approach to estimate adult…

  4. Artikel Jurnal

    Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016–2019

    Mariana Haeberer; Robin Bruyndonckx; Aleksandra Polkowska-Kramek dkk.

    Infectious Diseases and Therapy, Vol. 13 No. 3 · 2024 · Inggris · DOAJ Scopus

    Abstract Introduction Respiratory syncytial virus (RSV) causes a substantial disease burden among infants. In older children and adults, incidence is underestimated due to nonspecific symptoms and limited standard-of-care testing. We aimed to estimate RSV-attributable hospitalizations and deaths in…

  5. Artikel Jurnal

    Respiratory Syncytial Virus Risk Profile in Hospitalized Infants and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

    Mariana Haeberer; Martin Mengel; Rong Fan dkk.

    Infectious Diseases and Therapy, Vol. 13 No. 11 · 2024 · Inggris · DOAJ Scopus

    Abstract Introduction We aimed to describe the risk profile of RSV infections among children aged ≤ 24 months in Valladolid from January 2010 to August 2022 and to compare them with influenza and COVID-19 controls. Methods We conducted a retrospective cohort study of all laboratory-confirmed RSV…

  6. Artikel Jurnal

    RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

    Mariana Haeberer; Martin Mengel; Rong Fan dkk.

    Infectious Diseases and Therapy, Vol. 13 No. 9 · 2024 · Inggris · DOAJ Scopus

    Abstract Introduction We aimed to describe the risk profile of respiratory syncytial virus (RSV) infections among adults ≥ 60 years in Valladolid from January 2010 to August 2022, and to compare them with influenza and COVID-19 controls. Methods This was a retrospective cohort study of all…

  7. Artikel Jurnal

    Effectiveness of the 13-valent pneumococcal vaccine against hospitalized community-acquired pneumonia among adults ≥60 years in Madrid-Spain after the COVID-19 pandemic

    Maria Lahuerta; Angel Gil; Cristina Méndez dkk.

    Vaccine: X, Vol. 27 · 2025 · Inggris · DOAJ Scopus

    Background: Few data exist on vaccine effectiveness (VE) of the 13-valent pneumococcal conjugate vaccine (PCV13) against vaccine-type community acquired pneumonia (CAP) among adults, particularly for multiple years post-vaccination. We evaluated PCV13 VE among older adults in Spain right after the…